Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Long-Term Debt Repayments (2019 - 2020)

Phio Pharmaceuticals' Long-Term Debt Repayments history spans 5 years, with the latest figure at $9000.0 for Q3 2020.

  • For Q3 2020, Long-Term Debt Repayments changed N/A year-over-year to $9000.0; the TTM value through Jun 2021 reached $9000.0, down 62.5%, while the annual FY2020 figure was $27000.0, 350.0% up from the prior year.
  • Long-Term Debt Repayments reached $9000.0 in Q3 2020 per PHIO's latest filing, roughly flat from $9000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $9000.0 in Q1 2020 to a low of $6000.0 in Q4 2019.